Medline has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed public offering of its common stock.
Medline CEO Jim Boyle received $4.3 million in total compensation for 2024 — but he wasn't the top-paid executive for the year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback